AdaptHealth Corp.

NASDAQ:AHCO

10.09 (USD) • At close November 8, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q1
Revenue 805.858805.975792.497858.234804.031793.286744.626780.283557.654727.614706.203702.106653.293617.017482.119348.429284.405232.116191.439149.541136.451124.154119.498108.652102.15667.23567.235
Cost of Revenue 693.129690.368687.058709.823693.488673.397655.396699.322646.714610.011597.122591.62529.887490.72396.698290.38240.72197.517166.54123.212111.11198.04897.71790.02784.28755.44555.445
Gross Profit 112.729115.607105.439148.411110.543119.88989.2380.961-89.06117.603109.081110.486123.406126.29785.42158.04943.68534.59924.89926.32925.3426.10621.78118.62617.86911.7911.79
Gross Profit Ratio 0.140.1430.1330.1730.1370.1510.120.104-0.160.1620.1540.1570.1890.2050.1770.1670.1540.1490.130.1760.1860.210.1820.1710.1750.1750.175
Reseach & Development Expenses 000000000000000000000000000
General & Administrative Expenses 49.24257.01248.37847.29445.19850.07847.52137.45240.68142.54841.44434.92133.00642.94656.63231.60126.30617.09214.34724.9851.1951.7990.2910.4320.3910.1630.051
Selling & Marketing Expenses 09.20-1.13900019.200018.500000002.10001.788000
SG&A 49.24257.01248.37846.15545.19850.07847.52137.45240.68142.54841.44434.92133.00642.94656.63231.60126.30617.09214.34724.9851.1951.7990.2910.4320.3910.1630.051
Other Expenses 01.76-5.105-22.992-3.317-2.08215.53216.777-182.6915.87716.085-1.1340.452-1.6690.519-56.8674.121.0371.2422.9190.050.050.050.050.0540.0720.022
Operating Expenses 49.24257.01248.37846.15559.71365.62763.05354.229-142.00958.42557.52941.40747.69660.8970.01222.29930.42618.12915.58825.6151.2451.8490.3410.4820.4450.2340.073
Operating Income 63.48758.59557.061102.256-461.03654.26226.17726.73252.94959.17851.55269.07975.7165.40715.40935.7513.25916.479.3110.714-1.245-1.849-0.341-0.482-0.445-0.234-0.073
Operating Income Ratio 0.0790.0730.0720.119-0.5730.0680.0350.0340.0950.0810.0730.0980.1160.1060.0320.1030.0470.0710.0490.005-0.009-0.015-0.003-0.004-0.004-0.003-0.001
Total Other Income Expenses Net -31.459-30.816-51.56-373.942-506.023-1.27-11.216-23.57-30.142-35.078-3.719-9.97318.95550.1281.439-56.867-5.316-7.482-7.938-45.741.3671.4821.4641.4231.2051.1570.365
Income Before Tax 32.02827.7795.501-271.686-487.49920.4414.9613.16222.80724.147.83333.49570.41392.388-5.337-34.721-4.4638.9881.373-6.9390.122-0.3671.1230.9410.760.9220.292
Income Before Tax Ratio 0.040.0340.007-0.317-0.6060.0260.020.0040.0410.0330.0680.0480.1080.15-0.011-0.1-0.0160.0390.007-0.0460.001-0.0030.0090.0090.0070.0140.004
Income Tax Expense 8.0737.2486.61-18.111-34.5785.399-1.7144.7335.588.8535.60310.02412.14712.33-1.695-7.219-0.6361.8191.107-4.2880.2770.3010.2970.2840.2420.2320.072
Net Income 22.85919.435-2.134-254.503-454.07613.97715.707-1.57113.40212.84638.21321.13548.08872.199-3.966-31.043-2.4894.351-0.158-3.426-0.154-0.6670.8260.6580.5180.690.22
Net Income Ratio 0.0280.024-0.003-0.297-0.5650.0180.021-0.0020.0240.0180.0540.030.0740.117-0.008-0.089-0.0090.019-0.001-0.023-0.001-0.0050.0070.0060.0050.010.003
EPS 0.170.13-0.016-1.91-3.370.10.11-0.0120.10.0940.280.160.40.56-0.036-0.47-0.0430.1-0.004-0.11-0.007-0.0320.0260.0210.0170.0220.007
EPS Diluted 0.170.13-0.016-1.91-3.360.09-0.06-0.0120.0970.0940.280.150.20.12-0.034-0.47-0.0430.08-0.004-0.1-0.007-0.0310.0260.0210.0170.0220.007
EBITDA 73.624159.335162.922202.301144.823151.476118.81550.435145.023137.39122.922145.171145.9981.68229.308-16.14217.37934.84410.5521.344-1.245-1.849-0.341-0.482-0.445-0.234-0.073
EBITDA Ratio 0.0910.1980.2060.2360.180.1910.160.0650.260.1890.1740.2070.2230.1320.061-0.0460.0610.150.0550.009-0.009-0.015-0.003-0.004-0.004-0.003-0.001